Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
South Africa sleeping on the most successful HIV weapons

Oral pre-exposure prophylaxis (PrEP), taken as a once-daily pill, has been hailed the world over as one of the major HIV prevention interventions in the fight against AIDS. Yet, apart form sex workers, very few South Africans are using PrEP or even know it exists.

Published
03 December 2018
From
Health-e
The unexpected effects of the HIV prevention pill

PrEP is great at blocking HIV, but as its use grows, so do fears that people will be more sexually reckless and spread other STIs. But researchers are coming to think that the opposite could be true.

Published
29 November 2018
From
Mosaic
HIV diagnoses fell in the UK in 2017 for the first time among all risk groups, all ethnicities and in all regions, annual report reveals

The 2018 report from Public Health England is entitled Progress towards ending the HIV epidemic in the United Kingdom, and for once the note of optimism in

Published
29 November 2018
By
Gus Cairns
No new infections during research on preventive HIV pill in Belgium

According to the latest figures from Sciensano, 890 new diagnoses were made in Belgium last year, mainly in gay men and people from sub-Saharan Africa. This is a decrease of 27% compared to the peak of 2012.

Published
27 November 2018
From
Institute of Tropical Medicine
Call for minimum standards of PrEP provision and monitoring in Europe

Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV infection when it is taken correctly—once a day during times when the likelihood of becoming infected with HIV is very high, or, for gay men and other men who have sex with men, before and after sexual activity, so-called event-driven PrEP.

Published
27 November 2018
From
UNAIDS
High levels of unmet PrEP needs among transgender women in Brazil

A study recently published in The Journal of Acquired Immune Deficiency Syndromes indicates that transgender (trans) women in Brazil had low levels of pre-exposure prophylaxis (PrEP) awareness. This

Published
26 November 2018
By
Krishen Samuel
PrEP in the USA: white people given preference 

Nearly six times as many white people as black people are being prescribed pre-exposure prophylaxis (PrEP) in the USA, despite black people having a greater need. 

Published
26 November 2018
From
AVERT
Substance use does not lower adherence to PrEP in MSM

Study findings showed that substance use does not affect adherence to HIV pre-exposure prophylaxis, or PrEP, among men who have sex with men or transgender women.

Published
24 November 2018
From
Healio
HIV Seroconversion Despite PrEP Therapy

The tragedy of continued HIV transmission in the era of pre-exposure prophylaxis (PrEP) is explored in detail in a viewpoint article published in Clinical Infectious Diseases.1 The study evaluated a cohort of 14 young black men who have sex with men (MSM) in Atlanta, Georgia, who experienced HIV seroconversion despite administration of PrEP as part of the EleMENt Study.

Published
22 November 2018
From
Infectious Disease Advisor
PrEP Messaging: Using radio to reach communities with oral PrEP messages

Joel Odondi must be doing something right. The former chaplain for a girls’ school has become a trusted expert on HIV prevention to radio listeners across Kenya – delivering messages that correct misinformation, counter myths, explain scientific concepts, and frame public health debates on PrEP and a host of other issues related to HIV. Keeping an ear out especially for what young women need to hear, Odondi uses a powerful combination of responsiveness, accuracy and credibility to get the job done.

Published
13 November 2018
From
Prepwatch
← First123Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.